An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. [electronic resource]
Producer: 20030904Description: 526-35 p. digitalISSN:- 0012-3692
- Administration, Oral
- Amoxicillin-Potassium Clavulanate Combination -- administration & dosage
- Anti-Infective Agents -- administration & dosage
- Aza Compounds
- Clarithromycin
- Community-Acquired Infections -- drug therapy
- Cost-Benefit Analysis
- Drug Therapy, Combination
- Female
- Fluoroquinolones
- France
- Germany
- Hospitalization
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Moxifloxacin
- Pneumonia, Bacterial -- drug therapy
- Quinolines
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.